Citations

Showing 10 of 108119 citations.

A randomized phase II trial of the MET inhibitor tivantinib + cetuximab versus cetuximab alone in patients with recurrent/metastatic head and neck cancer.
Bauman, Julie E. , Lim, Dean, Sukari, Ammar , Wagner, Stephanie A., Curtis, Kelly K., Gitlitz, Barbara J. , Price, Katharine A. , Wade, James L. , Villaflor, Victoria , Souza, Jonas A. de, Karrison, Theodore , Vokes, Everett E. , Worden, Francis P. , Adkins, Douglas R. , Rao, Krishna A , Stadler, Walter M. , Seiwert, Tanguy Y.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 6060-6060

10.1200/jco.2015.33.15_suppl.6060 Get It

Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma.
Foster, Nathan R. , Meyers, Jeffrey P., Vasudeva, Shyamprasad Deraje, Katabi, Nora , Pfister, David G. , Horvath, Laura E., Erlichman, Charles , Ho, Alan L. , Antonescu, Cristina R. , Schwartz, Gary K.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 6039-6039

10.1200/jco.2015.33.15_suppl.6039 Get It

Use of homologous recombination deficiency (HRD) score to enrich for niraparib sensitive high grade ovarian tumors.
Wilcoxen, Keith, Becker, Marc A., Neff, Christopher, Abkevich, Victor, Jones, Joshua T., Hou, Xiaonan , Wang, Yan , Hartman, Anne‐Renee , AlHilli, Mariam , Gutin, Alexander , Agarwal, Shefali , Timms, Kirsten M. , Neff, Chris, Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5532-5532

10.1200/jco.2015.33.15_suppl.5532 Get It

A randomized, placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with AZD 1775 (MK 1775) in women with recurrent, platinum-resistant epithelial ovarian, primary peritoneal, or Fallopian tube cancers: Trial of
Lheureux, Stéphanie , Weberpals, Johanne I. , Hendrickson, Andrea E. Wahner , Olawaiye, Alexander , Mackay, Helen , Wilson, Michelle , Rodríguez-Freixinós, Víctor, Martín-Lorente, Cristina, Ward, Jacklyn, Chang, Karen, Wang, Lisa , Speers, Vanessa , Karakasis, Katherine, Bowering, Valerie , Chen, Alice P. , Fleming, Gini F. , Braña, Irene , Dhani, Neesha C. , Chang, Karen, Brenton, James D. , Oza, Amit M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS5613-TPS5613

10.1200/jco.2015.33.15_suppl.tps5613 Get It

Contemporary national trends of prostate cancer screening among privately insured patients in the United States.
Kim, Simon P. , Karnes, Jeffrey , Gross, Cary P. , Meropol, Neal J. , Houten, Holly K. Van , Abouassaly, Robert , Shah, Nilay D.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5065-5065

10.1200/jco.2015.33.15_suppl.5065 Get It

A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).
Qin, Rui , Sicotte, Hugues , Carlson, Rachel E. , Tan, Winston , Jiménez, Rafael E. , Wang, Liewei , Eckel‐Passow, Jeanette E. , Costello, Brian A. , Pitot, Henry C., Dronca, Roxana , Wu, Kevin J. , Moynihan, Timothy J. , Atwell, Thomas D. , McMenomy, Brendan P., Kohli, Manish , Wang, Liguo , Quevedo, Fernando , Ho, Thai H. , Bryce, Alan H. , Dehm, Scott M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2015.33.15_suppl.5056 Get It

Validation of a genomic classifier for prediction of metastasis following postoperative salvage radiation therapy.
Choeurng, Voleak, Plessis, Marguerite du, Yousefi, Kasra, Lam, Lucia L.C., Buerki, Christine, Trabulsi, Edouard J. , Dicker, Adam P. , Karnes, Jeffrey , Freedland, Stephen J. , Dicker, Adam P , Den, Robert B. , Davicioni, Elai , Howard, Lauren E. , Hoedt, Amanda M. De

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5016-5016

10.1200/jco.2015.33.15_suppl.5016 Get It

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
Hu, Brian , Fairey, Adrian, Madhav, Anisha, Li, Meng , Groshen, Susan , Stephens, Craig, Virk, Navneet, Martin, Sue Ellen , Erho, Nicholas , Jenkins, Robert B. , Xu, Tong , Xu, Yucheng, Goldkorn, Amir , Yang, Dongyun , Kim, Philip, Wang, Lina , Davicioni, Elai , Den, Robert B. , Gill, Inderbir S. , Quinn, David I

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16092-e16092

10.1200/jco.2015.33.15_suppl.e16092 Get It

Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).
Zhang, Ben Yiming, Riska, Shaun M., Lee, Adam M , Quevedo, Fernando , Costello, Brian A. , Pitot, Henry C., Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Silva, Fernando Eduardo Calais Da, Kochuparambil, Samith T. , Mahoney, Douglas W. , McDonnell, Shannon K. , Lee, Adam M. , Ribeiro, Ricardo , Medeiros, Rui , Cerhan, James R. , Kohli, Manish

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16117-e16117

10.1200/jco.2015.33.15_suppl.e16117 Get It

Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.
Zhang, Ben Yiming, Riska, Shaun M., Ribeiro, Ricardo , Medeiros, Rui , Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Calais-Da-Silva, Fernando, Costello, Brian A. , Dronca, Roxana , Pitot, Henry C., Moynihan, Timothy J. , Quevedo, Fernando , Mahoney, Douglas W. , Cerhan, James R. , Kohli, Manish

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2015.33.15_suppl.e16114 Get It